Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
DexCom, Inc.
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
IPO Date: April 14, 2005
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $32.54B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.73 | 2.05%
Avg Daily Range (30 D): $1.04 | 1.23%
Avg Daily Range (90 D): $1.44 | 1.91%
Institutional Daily Volume
Avg Daily Volume: .97M
Avg Daily Volume (30 D): 2.4M
Avg Daily Volume (90 D): 3.25M
Trade Size
Avg Trade Size (Sh.): 74
Avg Trade Size (Sh.) (30 D): 53
Avg Trade Size (Sh.) (90 D): 59
Institutional Trades
Total Inst.Trades: 17,895
Avg Inst. Trade: $7.15M
Avg Inst. Trade (30 D): $8.63M
Avg Inst. Trade (90 D): $7.55M
Avg Inst. Trade Volume: .13M
Avg Inst. Trades (Per Day): 5
Market Closing Trades
Avg Closing Trade: $22.77M
Avg Closing Trade (30 D): $47.4M
Avg Closing Trade (90 D): $50.68M
Avg Closing Volume: 332.43K
   
News
Jun 18, 2025 @ 5:00 PM
Global Artificial Pancreas Devices Market is Geari...
Source: Delveinsight
Jun 2, 2025 @ 12:11 PM
Goldman Sachs Bullish On Dexcom And Insulet As Dia...
Source: Vandana Singh
May 23, 2025 @ 9:52 AM
Blood Glucose Monitoring (BGM) Devices Market Repo...
Source: Researchandmarkets.Com
May 21, 2025 @ 5:47 PM
Diabetic Care Device Market Set for Significant Gr...
Source: Bcc Research
May 4, 2025 @ 1:52 PM
Duolingo, CoreWeave And DexCom Are Among Top 10 La...
Source: Lekha Gupta
Financials
  TTM Q1 2025 Q4 2024
Basic EPS $1.35 $.27 $.38
Diluted EPS $1.34 $.27 $.38
Revenue $ 4.15B $ 1.04B $ 1.11B
Gross Profit $ 2.47B $ 589M $ 655.8M
Net Income / Loss $ 535.2M $ 105.4M $ 151.7M
Operating Income / Loss $ 632.6M $ 133.7M $ 188.9M
Cost of Revenue $ 1.68B $ 447M $ 457.7M
Net Cash Flow $ 53.7M $ 298.8M $ -15.1M
PE Ratio 59.70    
Splits
Jun 13, 2022:   4:1